Industry: Medical Devices & Consumables
Published Date: 2025-01-16
Pages: 96 Pages
Report ld: 3457290
Request Sample
Customized Report
Serum Clot Activator Tubes Market Size(US$)

CAGR 2025-2031
6.7%
Market Size,2031
USD 697
Million
Market Snapshot
Source: Secondary research, interviews with experts, and QYResearch analysis
The global market for Serum Clot Activator Tubes was valued at US$ 445 million in the year 2024 and is projected to reach a revised size of US$ 697 million by 2031, growing at a CAGR of 6.7% during the forecast period.
Serum Clot Activator Tubes are used for clinical chemistry, immunology, protein electrophoresis, serology, microbiology and toxicology. The inner wall of the Serum Clot Activator tube is specially coated with clot activator, which activates the coagulation process.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
REPORT SCOPE
This report aims to provide a comprehensive presentation of the global market for Serum Clot Activator Tubes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Serum Clot Activator Tubes.
The Serum Clot Activator Tubes market size, estimations, and forecasts are provided in terms of sales volume (M Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Serum Clot Activator Tubes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Serum Clot Activator Tubes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
BD
Terumo
Greiner Bio-One
Medtronic
Sekisui
Sarstedt
Kangjian Medical
FL Medical
Improve Medical
Disera
Hongyu Medical
Vitrex Medical
KSMEDICAL
Chengdu PUTH Medical Plastics Packaging
Segment by Type
Plastic Tubes
Glass Tubes
Segment by Application
Hospital and Clinic
Laboratory
Others
Consumption by Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
U.A.E
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Serum Clot Activator Tubes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Serum Clot Activator Tubes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Serum Clot Activator Tubes Market Overview
1.1 Product Definition
1.2 Serum Clot Activator Tubes by Type
1.2.1 Global Serum Clot Activator Tubes Market Value Comparison by Type (2024 VS 2031)
1.2.2 Plastic Tubes
1.2.3 Glass Tubes
1.3 Serum Clot Activator Tubes by Application
1.3.1 Global Serum Clot Activator Tubes Market Value by Application (2024 VS 2031)
1.3.2 Hospital and Clinic
1.3.3 Laboratory
1.3.4 Others
1.4 Global Serum Clot Activator Tubes Market Size Estimates and Forecasts
1.4.1 Global Serum Clot Activator Tubes Revenue 2020-2031
1.4.2 Global Serum Clot Activator Tubes Sales 2020-2031
1.4.3 Global Serum Clot Activator Tubes Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Serum Clot Activator Tubes Market Competition by Manufacturers
2.1 Global Serum Clot Activator Tubes Sales Market Share by Manufacturers (2020-2025)
2.2 Global Serum Clot Activator Tubes Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Serum Clot Activator Tubes Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Serum Clot Activator Tubes, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Serum Clot Activator Tubes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Serum Clot Activator Tubes, Product Type & Application
2.7 Global Key Manufacturers of Serum Clot Activator Tubes, Date of Enter into This Industry
2.8 Global Serum Clot Activator Tubes Market Competitive Situation and Trends
2.8.1 Global Serum Clot Activator Tubes Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Serum Clot Activator Tubes Players Market Share by Revenue
2.8.3 Global Serum Clot Activator Tubes Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Serum Clot Activator Tubes Market Scenario by Region
3.1 Global Serum Clot Activator Tubes Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Serum Clot Activator Tubes Sales by Region: 2020-2031
3.2.1 Global Serum Clot Activator Tubes Sales by Region: 2020-2025
3.2.2 Global Serum Clot Activator Tubes Sales by Region: 2026-2031
3.3 Global Serum Clot Activator Tubes Revenue by Region: 2020-2031
3.3.1 Global Serum Clot Activator Tubes Revenue by Region: 2020-2025
3.3.2 Global Serum Clot Activator Tubes Revenue by Region: 2026-2031
3.4 North America Serum Clot Activator Tubes Market Facts & Figures by Country
3.4.1 North America Serum Clot Activator Tubes Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Serum Clot Activator Tubes Sales by Country (2020-2031)
3.4.3 North America Serum Clot Activator Tubes Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Serum Clot Activator Tubes Market Facts & Figures by Country
3.5.1 Europe Serum Clot Activator Tubes Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Serum Clot Activator Tubes Sales by Country (2020-2031)
3.5.3 Europe Serum Clot Activator Tubes Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Serum Clot Activator Tubes Market Facts & Figures by Region
3.6.1 Asia Pacific Serum Clot Activator Tubes Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Serum Clot Activator Tubes Sales by Region (2020-2031)
3.6.3 Asia Pacific Serum Clot Activator Tubes Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Serum Clot Activator Tubes Market Facts & Figures by Country
3.7.1 Latin America Serum Clot Activator Tubes Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Serum Clot Activator Tubes Sales by Country (2020-2031)
3.7.3 Latin America Serum Clot Activator Tubes Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Serum Clot Activator Tubes Market Facts & Figures by Country
3.8.1 Middle East and Africa Serum Clot Activator Tubes Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Serum Clot Activator Tubes Sales by Country (2020-2031)
3.8.3 Middle East and Africa Serum Clot Activator Tubes Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Serum Clot Activator Tubes Sales by Type (2020-2031)
4.1.1 Global Serum Clot Activator Tubes Sales by Type (2020-2025)
4.1.2 Global Serum Clot Activator Tubes Sales by Type (2026-2031)
4.1.3 Global Serum Clot Activator Tubes Sales Market Share by Type (2020-2031)
4.2 Global Serum Clot Activator Tubes Revenue by Type (2020-2031)
4.2.1 Global Serum Clot Activator Tubes Revenue by Type (2020-2025)
4.2.2 Global Serum Clot Activator Tubes Revenue by Type (2026-2031)
4.2.3 Global Serum Clot Activator Tubes Revenue Market Share by Type (2020-2031)
4.3 Global Serum Clot Activator Tubes Price by Type (2020-2031)
5 Segment by Application
5.1 Global Serum Clot Activator Tubes Sales by Application (2020-2031)
5.1.1 Global Serum Clot Activator Tubes Sales by Application (2020-2025)
5.1.2 Global Serum Clot Activator Tubes Sales by Application (2026-2031)
5.1.3 Global Serum Clot Activator Tubes Sales Market Share by Application (2020-2031)
5.2 Global Serum Clot Activator Tubes Revenue by Application (2020-2031)
5.2.1 Global Serum Clot Activator Tubes Revenue by Application (2020-2025)
5.2.2 Global Serum Clot Activator Tubes Revenue by Application (2026-2031)
5.2.3 Global Serum Clot Activator Tubes Revenue Market Share by Application (2020-2031)
5.3 Global Serum Clot Activator Tubes Price by Application (2020-2031)
6 Key Companies Profiled
6.1 BD
6.1.1 BD Company Information
6.1.2 BD Description and Business Overview
6.1.3 BD Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.1.4 BD Serum Clot Activator Tubes Product Portfolio
6.1.5 BD Recent Developments/Updates
6.2 Terumo
6.2.1 Terumo Company Information
6.2.2 Terumo Description and Business Overview
6.2.3 Terumo Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Terumo Serum Clot Activator Tubes Product Portfolio
6.2.5 Terumo Recent Developments/Updates
6.3 Greiner Bio-One
6.3.1 Greiner Bio-One Company Information
6.3.2 Greiner Bio-One Description and Business Overview
6.3.3 Greiner Bio-One Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Greiner Bio-One Serum Clot Activator Tubes Product Portfolio
6.3.5 Greiner Bio-One Recent Developments/Updates
6.4 Medtronic
6.4.1 Medtronic Company Information
6.4.2 Medtronic Description and Business Overview
6.4.3 Medtronic Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Medtronic Serum Clot Activator Tubes Product Portfolio
6.4.5 Medtronic Recent Developments/Updates
6.5 Sekisui
6.5.1 Sekisui Company Information
6.5.2 Sekisui Description and Business Overview
6.5.3 Sekisui Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sekisui Serum Clot Activator Tubes Product Portfolio
6.5.5 Sekisui Recent Developments/Updates
6.6 Sarstedt
6.6.1 Sarstedt Company Information
6.6.2 Sarstedt Description and Business Overview
6.6.3 Sarstedt Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Sarstedt Serum Clot Activator Tubes Product Portfolio
6.6.5 Sarstedt Recent Developments/Updates
6.7 Kangjian Medical
6.7.1 Kangjian Medical Company Information
6.7.2 Kangjian Medical Description and Business Overview
6.7.3 Kangjian Medical Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Kangjian Medical Serum Clot Activator Tubes Product Portfolio
6.7.5 Kangjian Medical Recent Developments/Updates
6.8 FL Medical
6.8.1 FL Medical Company Information
6.8.2 FL Medical Description and Business Overview
6.8.3 FL Medical Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.8.4 FL Medical Serum Clot Activator Tubes Product Portfolio
6.8.5 FL Medical Recent Developments/Updates
6.9 Improve Medical
6.9.1 Improve Medical Company Information
6.9.2 Improve Medical Description and Business Overview
6.9.3 Improve Medical Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Improve Medical Serum Clot Activator Tubes Product Portfolio
6.9.5 Improve Medical Recent Developments/Updates
6.10 Disera
6.10.1 Disera Company Information
6.10.2 Disera Description and Business Overview
6.10.3 Disera Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Disera Serum Clot Activator Tubes Product Portfolio
6.10.5 Disera Recent Developments/Updates
6.11 Hongyu Medical
6.11.1 Hongyu Medical Company Information
6.11.2 Hongyu Medical Description and Business Overview
6.11.3 Hongyu Medical Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Hongyu Medical Serum Clot Activator Tubes Product Portfolio
6.11.5 Hongyu Medical Recent Developments/Updates
6.12 Vitrex Medical
6.12.1 Vitrex Medical Company Information
6.12.2 Vitrex Medical Description and Business Overview
6.12.3 Vitrex Medical Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Vitrex Medical Serum Clot Activator Tubes Product Portfolio
6.12.5 Vitrex Medical Recent Developments/Updates
6.13 KSMEDICAL
6.13.1 KSMEDICAL Company Information
6.13.2 KSMEDICAL Description and Business Overview
6.13.3 KSMEDICAL Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.13.4 KSMEDICAL Serum Clot Activator Tubes Product Portfolio
6.13.5 KSMEDICAL Recent Developments/Updates
6.14 Chengdu PUTH Medical Plastics Packaging
6.14.1 Chengdu PUTH Medical Plastics Packaging Company Information
6.14.2 Chengdu PUTH Medical Plastics Packaging Description and Business Overview
6.14.3 Chengdu PUTH Medical Plastics Packaging Serum Clot Activator Tubes Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Chengdu PUTH Medical Plastics Packaging Serum Clot Activator Tubes Product Portfolio
6.14.5 Chengdu PUTH Medical Plastics Packaging Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Serum Clot Activator Tubes Industry Chain Analysis
7.2 Serum Clot Activator Tubes Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Serum Clot Activator Tubes Production Mode & Process Analysis
7.4 Serum Clot Activator Tubes Sales and Marketing
7.4.1 Serum Clot Activator Tubes Sales Channels
7.4.2 Serum Clot Activator Tubes Distributors
7.5 Serum Clot Activator Tubes Customer Analysis
8 Serum Clot Activator Tubes Market Dynamics
8.1 Serum Clot Activator Tubes Industry Trends
8.2 Serum Clot Activator Tubes Market Drivers
8.3 Serum Clot Activator Tubes Market Challenges
8.4 Serum Clot Activator Tubes Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global market for Serum Clot Activator Tubes was estimated to be worth US$ 472 million in 2025 and is projected to reach US$ 739 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-06-16
Pages: 142
USD 3950.00
(Single User License)
The global Serum Clot Activator Tubes market was valued at US$ 472 million in 2025 and is anticipated to reach US$ 739 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published Date: 2026-04-17
Pages: 125
USD 2900.00
(Single User License)
The global Serum Clot Activator Tubes market size was US$ 445 million in 2024 and is forecast to a readjusted size of US$ 697 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-11-02
Pages: 92
USD 4250.00
(Single User License)
The global Serum Clot Activator Tubes market is projected to grow from US$ 445 million in 2024 to US$ 697 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2025-11-02
Pages: 166
USD 4900.00
(Single User License)
The global market for Serum Clot Activator Tubes was estimated to be worth US$ 445 million in 2024 and is forecast to a readjusted size of US$ 697 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published Date: 2025-01-13
Pages: 121
USD 3950.00
(Single User License)
Serum Clot Activator Tubes are used for clinical chemistry, immunology, protein electrophoresis, serology, microbiology and toxicology. The inner wall of the Serum Clot Activator tube is specially coated with clot activator, which activates the coagulation process.
Published Date: 2024-01-11
Pages: 117
USD 3950.00
(Single User License)
The global market for Serum Clot Activator Tubes was estimated to be worth US$ 472 million in 2025 and is projected to reach US$ 739 million, growing at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-06-16
Pages: 142
The global Serum Clot Activator Tubes market was valued at US$ 472 million in 2025 and is anticipated to reach US$ 739 million by 2032, at a CAGR of 6.7% from 2026 to 2032.
Published: 2026-04-17
Pages: 125
The global Serum Clot Activator Tubes market size was US$ 445 million in 2024 and is forecast to a readjusted size of US$ 697 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-11-02
Pages: 92
The global Serum Clot Activator Tubes market is projected to grow from US$ 445 million in 2024 to US$ 697 million by 2031, at a CAGR of 6.7% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2025-11-02
Pages: 166
The global market for Serum Clot Activator Tubes was estimated to be worth US$ 445 million in 2024 and is forecast to a readjusted size of US$ 697 million by 2031 with a CAGR of 6.7% during the forecast period 2025-2031.
Published: 2025-01-13
Pages: 121
Serum Clot Activator Tubes are used for clinical chemistry, immunology, protein electrophoresis, serology, microbiology and toxicology. The inner wall of the Serum Clot Activator tube is specially coated with clot activator, which activates the coagulation process.
Published: 2024-01-11
Pages: 117
REPORT COVERAGE
DESCRIPTION
OVERVIEW
REPORT SCOPE
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now